Vimseltinib versus Placebo for Tenosynovial Giant Cell Tumour (MOTION): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial.|Citation only
Vimseltinib versus Placebo for Tenosynovial Giant Cell Tumour (MOTION): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial.|Citation only